Skip to main navigation menu Skip to main content Skip to site footer

Technical comment

Vol. 141 No. 4748 (2011)

Letter to the editor

  • FJ Fernández-Fernández
DOI
https://doi.org/10.4414/smw.2011.13300
Cite this as:
Swiss Med Wkly. 2011;141:w13300
Published
21.11.2011

References

  1. Meier C, Kraenzlin ME. Calcium supplementation, osteoporosis and cardiovascular disease. Swiss Med Wkly. 2011;141:w13260 http://www.smw.ch/content/smw-2011-13260/.
  2. Vermeer C, Braam L. Role of K vitamins in the regulation of tissue calcification. J Bone Miner Metab. 2001;19:201–6.
  3. Fusaro M, et al. Vitamin K, bone fractures, and vascular calcifications in chronic kidney disease: an important but poorly studied relationship. J Endocrinol Invest. 2011;34:317–23.
  4. Geleijnse JM, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: The Rotterdam Study. J Nutr. 2004;134:3100–5.
  5. Holden RM, et al. Warfarin and aortic valve calcification in hemodialysis patients. J Nephrol. 2007;20:417–22.
  6. Krüger T, Floege J. Coumarin use in dialysis patients with atrial fibrillation – more harm than benefit? Nephrol Dial Transplant. 2009;24:3284–5.
  7. Schurgers LJ, Aebert H, Vermeer C, Bültmann B, Janzen J. Oral anticoagulant treatment: friend or foe in cardiovascular disease? Blood. 2004;104:3231–2.